Higher versus lower blood pressure targets for vasopressor therapy in shock: A multicentre pilot randomized controlled trial

Intensive Care Medicine

Volumn 42, Issue 4, 2016, Pages 542-550

  Lamontagne, François ^a,b   Meade, Maureen O ^c   Hébert, Paul C ^d   Asfar, Pierre ^e   Lauzier, François ^f,u   Seely, Andrew J E ^g,h   Day, Andrew G ⁱ   Mehta, Sangeeta ^j   Muscedere, John ^k   Bagshaw, Sean M ^l   Ferguson, Niall D ^j   Cook, Deborah J ^c   Kanji, Salmaan ^h   Turgeon, Alexis F ^f,u   Herridge, Margaret S ^j   Subramanian, Sanjay ^m   Lacroix, Jacques ⁿ   Adhikari, Neill K J ^j,o   Scales, Damon C ^j,o   Fox Robichaud, Alison ^c   Skrobik, Yoanna ^p   Whitlock, Richard P ^c,q   Green, Robert S ^r   Koo, Karen K Y ^s   Tanguay, Teddie ^t   Magder, Sheldon ^p   Heyland, Daren K ⁱ   more..

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e ANGERS UNIVERSITY HOSPITAL   (France)

^f UNIVERSITÉ LAVAL   (Canada)

^g UNIVERSITY OF OTTAWA   (Canada)

^h OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

ⁱ KINGSTON GENERAL HOSPITAL   (Canada)

^j UNIVERSITY OF TORONTO   (Canada)

^k QUEEN S UNIVERSITY   (Canada)

^l UNIVERSITY OF ALBERTA   (Canada)

^m SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ UNIVERSITY OF MONTREAL   (Canada)

^o SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^p MCGILL UNIVERSITY   (Canada)

^q MCMASTER UNIVERSITY   (Canada)

^r DALHOUSIE UNIVERSITY   (Canada)

^s SWEDISH MEDICAL CENTER   (United States)

^t Canadian Association of Critical Care Nurses   (Canada)

^u LAVAL UNIVERSITY   (Canada)

more..

Author keywords

Blood pressure targets; Resuscitation; Shock; Vasopressors

Indexed keywords

VASOCONSTRICTOR AGENT;

ADOLESCENT; ADULT; AGED; ARTERIAL PRESSURE; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLICATION; CONTROLLED STUDY; DRUG EFFECTS; FEMALE; HUMAN; HYPOTENSION; MALE; MIDDLE AGED; MULTICENTER STUDY; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; SHOCK; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTERIAL PRESSURE; FEMALE; HUMANS; HYPOTENSION; MALE; MIDDLE AGED; PILOT PROJECTS; SHOCK; VASOCONSTRICTOR AGENTS;

EID: 84958770883     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-016-4237-3     Document Type: Article

References (19)

1. Angus DC, van der Poll T (2013) Severe sepsis and septic shock. N Engl J Med 369:2063. doi:10.1056/NEJMc1312359
2. Vincent JL, De Backer D (2013) Circulatory shock. N Engl J Med 369:1726– 1734. doi:10.1056/NEJMra1208943
3. Bellomo R, Kellum JA, Wisniewski SR et al (1999) Effects of norepinephrine on the renal vasculature in normal and endotoxemic dogs. Am J Respir Crit Care Med 159:1186–1192. doi:10.1164/ajrccm.159.4.9802055
4. Dunser MW, Mayr AJ, Tur A et al (2003) Ischemic skin lesions as a com-plication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: incidence and risk factors. Crit Care Med 31:1394– 1398. doi:10.1097/01.CCM.0000059722.94182.79
5. Schmittinger CA, Torgersen C, Luckner G et al (2012) Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study. Intensive Care Med 38:950–958. doi:10.1007/s00134-012-2531-2s
6. Weil MH, Tang W (2009) Challenging the rationale of routine vasopressor therapy for management of hypotension. Crit Care 13:179. doi:10.1186/cc7976
7. Dellinger RP, Levy MM, Rhodes A et al (2013) Surviving Sepsis Cam-paign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41:580–637. doi:10.1097/CCM.0b013e31827e83af
8. Mouncey PR, Osborn TM, Power GS et al (2015) Trial of early, goal-directed resuscitation for septic shock. N Engl J Med 372:1301–1311. doi:10.1056/NEJMoa1500896
9. Peake SL, Delaney A, Bailey M et al (2014) Goal-directed resuscitation for patients with early septic shock. N Engl J Med 371:1496–1506. doi:10.1056/NEJMoa1404380
10. Yealy DM, Kellum JA, Huang DT et al (2014) A randomized trial of protocol-based care for early septic shock. N Engl J Med 370:1683–1693. doi:10.1056/NEJMoa1401602
11. Asfar P, Meziani F, Hamel JF et al (2014) High versus low blood-pressure target in patients with septic shock. N Engl J Med. doi:10.1056/NEJMoa1312173
12. De Backer D, Aldecoa C, Njimi H et al (2012) Dopamine versus norepi-nephrine in the treatment of septic shock: a meta-analysis. Crit Care Med 40:725–730. doi:10.1097/CCM.0b013e31823778ee
13. De Backer D, Biston P, Devriendt J et al (2010) Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 362:779– 789. doi:10.1056/NEJMoa0907118
14. Panwar R, Lanyon N, Davies AR et al (2013) Mean perfusion pressure deficit during the initial management of shock–an observational cohort study. J Crit Care 28:816–824. doi:10.1016/j.jcrc.2013.05.009
15. D’Aragon F, Belley-Cote EP, Meade MO et al (2015) Blood pressure targets for vasopressor therapy: a systematic review. Shock 43:530–539. doi:10.1097/SHK.0000000000000348
16. Heyland DK, Muscedere J, Drover J et al (2011) Persistent organ dysfunction plus death: a novel, composite outcome measure for critical care trials. Crit Care 15:R98. doi:10.1186/cc10110
17. Vincent JL, Moreno R, Takala J et al (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707–710
18. Hinkle JL, McClaran J, Davies J et al (2010) Reliability and validity of the adult alpha functional independence measure instrument in England. J Neurosci Nurs 42:12–18
19. Brown SM, Lanspa MJ, Jones JP et al (2013) Survival after shock requir-ing high-dose vasopressor therapy. Chest 143:664–671. doi:10.1378/chest.12-1106